A buildup inside cancer cells helped stomach cancer spread to the liver in mice. The substance was Methylmalonic Acid (MMA). The study combined lab tests, gene data from people with stomach cancer, and mouse experiments. Researchers switched off genes to find what helped cancer cells invade nearby tissue. They found a protective protein called ALDH6A1. This protein helps break down valine, one of the building blocks of protein. When cancer cells made too little ALDH6A1, that breakdown process stalled. The acid then built up inside cells. It blocked another protein that helps control which genes stay active. This turned up genes that helped cancer cells spread. In mice, these changes promoted spread from the stomach to the liver. Researchers also tested ways to interrupt this process. Alda-1, a compound that activates ALDH6A1, reduced cancer spread. So did l-carnitine, used in the experiments to help clear the acid. The source summary gives no group sizes or numbers showing how much spread fell. These findings point to a possible treatment target, not a proven treatment for people. For this community, a change inside cancer cells is not a blood-test risk score. This study does not show that a high routine blood result predicts cancer. Many members track this marker to understand usable Vitamin B12. That is a different setting from these experiments. When comparing results with the community, dates, units, and reasons for testing add useful context. What have your own results shown over time, and what led you to track them?